Industry: Chemical & Material
Published Date: 2024-01-18
Pages: 90 Pages
Report ld: 2313012
Request Sample
Customized Report
Pharma Grade Diosgenin Market Size(US$)

CAGR 2024-2030
6.5%
Market Size,2030
USD 106.7
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Diosgenin is a natural steroidal saponin, whose structure is very similar to endogenous steroids (such as cholesterol, progesterone, and estrogen). Due to its estrogenic activity, it is often used as a precursor for producing norethindrone and progesterone and as a dietary supplement in hormone replacement therapy to improve menopausal symptoms.
The global Pharma Grade Diosgenin market was valued at US$ 67 million in 2023 and is anticipated to reach US$ 106.7 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharma Grade Diosgenin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Grade Diosgenin.
MARKET SEGMENTATION
REPORT SCOPE
The Pharma Grade Diosgenin market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharma Grade Diosgenin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma Grade Diosgenin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharma Grade Diosgenin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharma Grade Diosgenin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharma Grade Diosgenin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Pharma Grade Diosgenin Market Overview
1.1 Product Definition
1.2 Pharma Grade Diosgenin Segment by Type
1.2.1 Global Pharma Grade Diosgenin Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 0.97
1.2.3 0.98
1.2.4 Others
1.3 Pharma Grade Diosgenin Segment by Application
1.3.1 Global Pharma Grade Diosgenin Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Functional Food & Health Products
1.4 Global Market Growth Prospects
1.4.1 Global Pharma Grade Diosgenin Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Pharma Grade Diosgenin Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Pharma Grade Diosgenin Production Estimates and Forecasts (2019-2030)
1.4.4 Global Pharma Grade Diosgenin Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharma Grade Diosgenin Production Market Share by Manufacturers (2019-2024)
2.2 Global Pharma Grade Diosgenin Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Pharma Grade Diosgenin, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Pharma Grade Diosgenin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Pharma Grade Diosgenin Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Pharma Grade Diosgenin, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharma Grade Diosgenin, Product Offered and Application
2.8 Global Key Manufacturers of Pharma Grade Diosgenin, Date of Enter into This Industry
2.9 Pharma Grade Diosgenin Market Competitive Situation and Trends
2.9.1 Pharma Grade Diosgenin Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pharma Grade Diosgenin Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharma Grade Diosgenin Production by Region
3.1 Global Pharma Grade Diosgenin Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Pharma Grade Diosgenin Production Value by Region (2019-2030)
3.2.1 Global Pharma Grade Diosgenin Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Pharma Grade Diosgenin by Region (2025-2030)
3.3 Global Pharma Grade Diosgenin Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Pharma Grade Diosgenin Production by Region (2019-2030)
3.4.1 Global Pharma Grade Diosgenin Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Pharma Grade Diosgenin by Region (2025-2030)
3.5 Global Pharma Grade Diosgenin Market Price Analysis by Region (2019-2024)
3.6 Global Pharma Grade Diosgenin Production and Value, Year-over-Year Growth
3.6.1 North America Pharma Grade Diosgenin Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Pharma Grade Diosgenin Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Pharma Grade Diosgenin Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Pharma Grade Diosgenin Production Value Estimates and Forecasts (2019-2030)
4 Pharma Grade Diosgenin Consumption by Region
4.1 Global Pharma Grade Diosgenin Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Pharma Grade Diosgenin Consumption by Region (2019-2030)
4.2.1 Global Pharma Grade Diosgenin Consumption by Region (2019-2024)
4.2.2 Global Pharma Grade Diosgenin Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Pharma Grade Diosgenin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Pharma Grade Diosgenin Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharma Grade Diosgenin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Pharma Grade Diosgenin Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharma Grade Diosgenin Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Pharma Grade Diosgenin Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharma Grade Diosgenin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Pharma Grade Diosgenin Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Pharma Grade Diosgenin Production by Type (2019-2030)
5.1.1 Global Pharma Grade Diosgenin Production by Type (2019-2024)
5.1.2 Global Pharma Grade Diosgenin Production by Type (2025-2030)
5.1.3 Global Pharma Grade Diosgenin Production Market Share by Type (2019-2030)
5.2 Global Pharma Grade Diosgenin Production Value by Type (2019-2030)
5.2.1 Global Pharma Grade Diosgenin Production Value by Type (2019-2024)
5.2.2 Global Pharma Grade Diosgenin Production Value by Type (2025-2030)
5.2.3 Global Pharma Grade Diosgenin Production Value Market Share by Type (2019-2030)
5.3 Global Pharma Grade Diosgenin Price by Type (2019-2030)
6 Segment by Application
6.1 Global Pharma Grade Diosgenin Production by Application (2019-2030)
6.1.1 Global Pharma Grade Diosgenin Production by Application (2019-2024)
6.1.2 Global Pharma Grade Diosgenin Production by Application (2025-2030)
6.1.3 Global Pharma Grade Diosgenin Production Market Share by Application (2019-2030)
6.2 Global Pharma Grade Diosgenin Production Value by Application (2019-2030)
6.2.1 Global Pharma Grade Diosgenin Production Value by Application (2019-2024)
6.2.2 Global Pharma Grade Diosgenin Production Value by Application (2025-2030)
6.2.3 Global Pharma Grade Diosgenin Production Value Market Share by Application (2019-2030)
6.3 Global Pharma Grade Diosgenin Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Sabinsa
7.1.1 Sabinsa Pharma Grade Diosgenin Corporation Information
7.1.2 Sabinsa Pharma Grade Diosgenin Product Portfolio
7.1.3 Sabinsa Pharma Grade Diosgenin Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Sabinsa Main Business and Markets Served
7.1.5 Sabinsa Recent Developments/Updates
7.2 Himachal Pharmaceuticals
7.2.1 Himachal Pharmaceuticals Pharma Grade Diosgenin Corporation Information
7.2.2 Himachal Pharmaceuticals Pharma Grade Diosgenin Product Portfolio
7.2.3 Himachal Pharmaceuticals Pharma Grade Diosgenin Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Himachal Pharmaceuticals Main Business and Markets Served
7.2.5 Himachal Pharmaceuticals Recent Developments/Updates
7.3 Namiex Chemicals
7.3.1 Namiex Chemicals Pharma Grade Diosgenin Corporation Information
7.3.2 Namiex Chemicals Pharma Grade Diosgenin Product Portfolio
7.3.3 Namiex Chemicals Pharma Grade Diosgenin Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Namiex Chemicals Main Business and Markets Served
7.3.5 Namiex Chemicals Recent Developments/Updates
7.4 Zhenhua Biology
7.4.1 Zhenhua Biology Pharma Grade Diosgenin Corporation Information
7.4.2 Zhenhua Biology Pharma Grade Diosgenin Product Portfolio
7.4.3 Zhenhua Biology Pharma Grade Diosgenin Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Zhenhua Biology Main Business and Markets Served
7.4.5 Zhenhua Biology Recent Developments/Updates
7.5 Shaanxi Jiahe Biotechnology
7.5.1 Shaanxi Jiahe Biotechnology Pharma Grade Diosgenin Corporation Information
7.5.2 Shaanxi Jiahe Biotechnology Pharma Grade Diosgenin Product Portfolio
7.5.3 Shaanxi Jiahe Biotechnology Pharma Grade Diosgenin Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Shaanxi Jiahe Biotechnology Main Business and Markets Served
7.5.5 Shaanxi Jiahe Biotechnology Recent Developments/Updates
7.6 Shaanxi Haochen Biotechnology
7.6.1 Shaanxi Haochen Biotechnology Pharma Grade Diosgenin Corporation Information
7.6.2 Shaanxi Haochen Biotechnology Pharma Grade Diosgenin Product Portfolio
7.6.3 Shaanxi Haochen Biotechnology Pharma Grade Diosgenin Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Shaanxi Haochen Biotechnology Main Business and Markets Served
7.6.5 Shaanxi Haochen Biotechnology Recent Developments/Updates
7.7 lofty creatures
7.7.1 lofty creatures Pharma Grade Diosgenin Corporation Information
7.7.2 lofty creatures Pharma Grade Diosgenin Product Portfolio
7.7.3 lofty creatures Pharma Grade Diosgenin Production, Value, Price and Gross Margin (2019-2024)
7.7.4 lofty creatures Main Business and Markets Served
7.7.5 lofty creatures Recent Developments/Updates
7.8 Xi'an Weiao Biotechnology
7.8.1 Xi'an Weiao Biotechnology Pharma Grade Diosgenin Corporation Information
7.8.2 Xi'an Weiao Biotechnology Pharma Grade Diosgenin Product Portfolio
7.8.3 Xi'an Weiao Biotechnology Pharma Grade Diosgenin Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Xi'an Weiao Biotechnology Main Business and Markets Served
7.7.5 Xi'an Weiao Biotechnology Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharma Grade Diosgenin Industry Chain Analysis
8.2 Pharma Grade Diosgenin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharma Grade Diosgenin Production Mode & Process
8.4 Pharma Grade Diosgenin Sales and Marketing
8.4.1 Pharma Grade Diosgenin Sales Channels
8.4.2 Pharma Grade Diosgenin Distributors
8.5 Pharma Grade Diosgenin Customers
9 Pharma Grade Diosgenin Market Dynamics
9.1 Pharma Grade Diosgenin Industry Trends
9.2 Pharma Grade Diosgenin Market Drivers
9.3 Pharma Grade Diosgenin Market Challenges
9.4 Pharma Grade Diosgenin Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Pharma Grade Diosgenin was estimated to be worth US$ 81.9 million in 2025 and is projected to reach US$ 126 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 133
USD 3950.00
(Single User License)
The global Pharma Grade Diosgenin market was valued at US$ 81.9 million in 2025 and is anticipated to reach US$ 126 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 130
USD 2900.00
(Single User License)
The global Pharma Grade Diosgenin market size was US$ 77.4 million in 2024 and is forecast to a readjusted size of US$ 120 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 79
USD 4250.00
(Single User License)
The global Pharma Grade Diosgenin market is projected to grow from US$ 77.4 million in 2024 to US$ 120 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 143
USD 4900.00
(Single User License)
The global market for Pharma Grade Diosgenin was estimated to be worth US$ 77.4 million in 2024 and is forecast to a readjusted size of US$ 120 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 91
USD 3950.00
(Single User License)
The global market for Pharma Grade Diosgenin was valued at US$ 77.4 million in the year 2024 and is projected to reach a revised size of US$ 120 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published Date: 2025-01-16
Pages: 94
USD 2900.00
(Single User License)
Diosgenin is a natural steroidal saponin, whose structure is very similar to endogenous steroids (such as cholesterol, progesterone, and estrogen). Due to its estrogenic activity, it is often used as a precursor for producing norethindrone and progesterone and as a dietary supplement in hormone replacement therapy to improve menopausal symptoms.
Published Date: 2024-04-15
Pages: 98
USD 4900.00
(Single User License)
Diosgenin is a natural steroidal saponin, whose structure is very similar to endogenous steroids (such as cholesterol, progesterone, and estrogen). Due to its estrogenic activity, it is often used as a precursor for producing norethindrone and progesterone and as a dietary supplement in hormone replacement therapy to improve menopausal symptoms.
Published Date: 2024-01-15
Pages: 96
USD 3950.00
(Single User License)
The global market for Pharma Grade Diosgenin was estimated to be worth US$ 81.9 million in 2025 and is projected to reach US$ 126 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-06-16
Pages: 133
The global Pharma Grade Diosgenin market was valued at US$ 81.9 million in 2025 and is anticipated to reach US$ 126 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-04-18
Pages: 130
The global Pharma Grade Diosgenin market size was US$ 77.4 million in 2024 and is forecast to a readjusted size of US$ 120 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 79
The global Pharma Grade Diosgenin market is projected to grow from US$ 77.4 million in 2024 to US$ 120 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 143
The global market for Pharma Grade Diosgenin was estimated to be worth US$ 77.4 million in 2024 and is forecast to a readjusted size of US$ 120 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 91
The global market for Pharma Grade Diosgenin was valued at US$ 77.4 million in the year 2024 and is projected to reach a revised size of US$ 120 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published: 2025-01-16
Pages: 94
Diosgenin is a natural steroidal saponin, whose structure is very similar to endogenous steroids (such as cholesterol, progesterone, and estrogen). Due to its estrogenic activity, it is often used as a precursor for producing norethindrone and progesterone and as a dietary supplement in hormone replacement therapy to improve menopausal symptoms.
Published: 2024-04-15
Pages: 98
Diosgenin is a natural steroidal saponin, whose structure is very similar to endogenous steroids (such as cholesterol, progesterone, and estrogen). Due to its estrogenic activity, it is often used as a precursor for producing norethindrone and progesterone and as a dietary supplement in hormone replacement therapy to improve menopausal symptoms.
Published: 2024-01-15
Pages: 96
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now